Skip to main content
Erschienen in: Acta Neuropathologica 1/2009

01.01.2009 | Original Paper

Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson’s disease and dementia with Lewy bodies

verfasst von: John H. T. Power, Peter C. Blumbergs

Erschienen in: Acta Neuropathologica | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Glutathione peroxidase (GPx-1) is regarded as one of the mammalian cell’s main antioxidant enzymes inactivating hydrogen peroxide and protecting against oxidative stress. Using control, Parkinson’s disease (PD), and dementia with Lewy bodies tissue (DLB) we have shown that GPx-1 is a 21-kD protein under reducing conditions in all tissues examined but is not in high abundance in human brain. Using immunohistochemistry we have mapped the cellular distribution of GPx-1 and have shown it to be in highest levels in microglia and with lower levels in neurons. Only a trace amount was detectable in astrocytes using immunofluorescence and GPx-1 was not detectable in oligodendrocytes. GPx-1 positive microglia were hypertrophied and more abundant in PD and DLB tissues and were seen to be making multiple contacts with neurons. In some cases neurons containing Lewy bodies were surrounded by microglia. Unstructured Lewy bodies were enveloped with a layer of GPx-1 that was partially colocalized with α-synuclein whereas concentric Lewy bodies had discrete deposits of GPx-1 around the periphery which appeared to be involved in the degradation of the Lewy bodies. These results suggest that abnormal α-synuclein as found in Lewy bodies produce hydrogen peroxide and these neurons are capable of directing antioxidant enzymes to regions of oxidative stress. These results also suggest that GPx-1 positive microglia are involved in neuroprotection in PD and DLB and that GPx-1 is an important antioxidant enzyme in neuronal defences.
Literatur
3.
Zurück zum Zitat Crack PJ, Taylor JM, Flentjar NJ, de Haan J, Hertzog P, Iannello RC, Kola I (2001) Increased infarct size and exacerbated apoptosis in the glutathione peroxidase-1 (Gpx-1) knockout mouse brain in response to ischemia/reperfusion injury. J Neurochem 78:1389–1399. doi:10.1046/j.1471-4159.2001.00535.x PubMedCrossRef Crack PJ, Taylor JM, Flentjar NJ, de Haan J, Hertzog P, Iannello RC, Kola I (2001) Increased infarct size and exacerbated apoptosis in the glutathione peroxidase-1 (Gpx-1) knockout mouse brain in response to ischemia/reperfusion injury. J Neurochem 78:1389–1399. doi:10.​1046/​j.​1471-4159.​2001.​00535.​x PubMedCrossRef
5.
Zurück zum Zitat Deng Y, Lu J, Sivakumar V, Ling EA, Kaur C (2008) Amoeboid microglia in the periventricular white matter induce oligodendrocyte damage through expression of proinflammatory cytokines via MAP kinase signaling pathway hypoxic neonatal rats. Brain Pathol 18:387–400. doi:10.1111/j.1750-3639.2008.00138.x PubMedCrossRef Deng Y, Lu J, Sivakumar V, Ling EA, Kaur C (2008) Amoeboid microglia in the periventricular white matter induce oligodendrocyte damage through expression of proinflammatory cytokines via MAP kinase signaling pathway hypoxic neonatal rats. Brain Pathol 18:387–400. doi:10.​1111/​j.​1750-3639.​2008.​00138.​x PubMedCrossRef
7.
Zurück zum Zitat Flentjar HJ, Crack PJ, Boyd R, Malin M, de Haan JB, Hertzog KolaI, Iannello R (2002) Mice lacking glutathione peroxidase-1 activity show increased tunel staining and an accelerated inflammatory response in brain following a cold-induced injury. Exp Neurol 177:9–20. doi:10.1006/exnr.2002.7927 PubMedCrossRef Flentjar HJ, Crack PJ, Boyd R, Malin M, de Haan JB, Hertzog KolaI, Iannello R (2002) Mice lacking glutathione peroxidase-1 activity show increased tunel staining and an accelerated inflammatory response in brain following a cold-induced injury. Exp Neurol 177:9–20. doi:10.​1006/​exnr.​2002.​7927 PubMedCrossRef
9.
Zurück zum Zitat Gai QP, Yuan HX, Power JHT, Blumbergs PC, Jensen PH (2000) In situ and in vitro study of colocalization and segregation of α-synuclein, ubiquitin and lipids in Lewy bodies. Exp Neurol 166:324–333. doi:10.1006/exnr.2000.7527 PubMedCrossRef Gai QP, Yuan HX, Power JHT, Blumbergs PC, Jensen PH (2000) In situ and in vitro study of colocalization and segregation of α-synuclein, ubiquitin and lipids in Lewy bodies. Exp Neurol 166:324–333. doi:10.​1006/​exnr.​2000.​7527 PubMedCrossRef
10.
Zurück zum Zitat Hashimoto M, Hse LJ, Xia Y, Takeda A, Sisk A, Sundsmo M, Masliah E (1999) Oxidative stress induces amyloid-like aggregate formation on NACP/α-synuclein in vitro. Neuroreport 10:717–721PubMedCrossRef Hashimoto M, Hse LJ, Xia Y, Takeda A, Sisk A, Sundsmo M, Masliah E (1999) Oxidative stress induces amyloid-like aggregate formation on NACP/α-synuclein in vitro. Neuroreport 10:717–721PubMedCrossRef
12.
Zurück zum Zitat Kang JH, Kim KS (2003) Enhanced oligomerization of the α-synuclein mutant by the Cu, Zn-superoxide dismutase and hydrogen peroxide system. Mol Cells 15:87–93PubMed Kang JH, Kim KS (2003) Enhanced oligomerization of the α-synuclein mutant by the Cu, Zn-superoxide dismutase and hydrogen peroxide system. Mol Cells 15:87–93PubMed
14.
Zurück zum Zitat Lee MK, Stirling W, Xu Y, Xu X, Qui D, Mandir AS, Dawson TM, Copeland NG, Jenkins NA, Price DL (2002) Human α-synuclein-harboring familial Parkinson’s disease-linked Ala–53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice. Proc Natl Acad Sci USA 99:8968–8973. doi:10.1073/pnas.132197599 PubMedCrossRef Lee MK, Stirling W, Xu Y, Xu X, Qui D, Mandir AS, Dawson TM, Copeland NG, Jenkins NA, Price DL (2002) Human α-synuclein-harboring familial Parkinson’s disease-linked Ala–53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice. Proc Natl Acad Sci USA 99:8968–8973. doi:10.​1073/​pnas.​132197599 PubMedCrossRef
15.
Zurück zum Zitat Lindenau J, Noack H, Asayama K, Wolf G (1998) Enhanced cellular glutathione peroxidase immunoreactivity in activated astrocytes and in microglia during excitotoxin induced neurodegeneration. Glia 24:252–256. doi:10.1002/(SICI)1098-1136(199810)24:2<252::AID-GLIA10>3.0.CO;2-ZPubMedCrossRef Lindenau J, Noack H, Asayama K, Wolf G (1998) Enhanced cellular glutathione peroxidase immunoreactivity in activated astrocytes and in microglia during excitotoxin induced neurodegeneration. Glia 24:252–256. doi:10.1002/(SICI)1098-1136(199810)24:2<252::AID-GLIA10>3.0.CO;2-ZPubMedCrossRef
17.
Zurück zum Zitat McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa d, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday g, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VMY, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier S, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies. Neurology 65:1863–1872. doi:10.1212/01.wnl.0000187889.17253.b1 PubMedCrossRef McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa d, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday g, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VMY, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier S, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies. Neurology 65:1863–1872. doi:10.​1212/​01.​wnl.​0000187889.​17253.​b1 PubMedCrossRef
19.
Zurück zum Zitat Panov A, Dikalov S, Shalbuyeva N, Taylor G, Sherer T, Greenamyre JT (2005) Rotenone model of Parkinson’s disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication. J Biol Chem 280:42026–42035. doi:10.1074/jbc.M508628200 PubMedCrossRef Panov A, Dikalov S, Shalbuyeva N, Taylor G, Sherer T, Greenamyre JT (2005) Rotenone model of Parkinson’s disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication. J Biol Chem 280:42026–42035. doi:10.​1074/​jbc.​M508628200 PubMedCrossRef
20.
Zurück zum Zitat Power JHT, Asad S, Chataway T, Chegini F, Manavis J, Temlett JA, Jensen PH, Blumbergs PC, Gai W (2008) Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer’s disease pathology. Acta Neuropathol 115:611–622. doi:10.1007/s00401-008-0373-3 PubMedCrossRef Power JHT, Asad S, Chataway T, Chegini F, Manavis J, Temlett JA, Jensen PH, Blumbergs PC, Gai W (2008) Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer’s disease pathology. Acta Neuropathol 115:611–622. doi:10.​1007/​s00401-008-0373-3 PubMedCrossRef
21.
Zurück zum Zitat Power JHT, Shannon JM, Blumbergs PC, Gai W (2002) Nonselenium glutathione peroxidase in human brain: elevated levels in Parkinson’s disease and dementia with Lewy bodies. Am J Pathol 161:885–894PubMed Power JHT, Shannon JM, Blumbergs PC, Gai W (2002) Nonselenium glutathione peroxidase in human brain: elevated levels in Parkinson’s disease and dementia with Lewy bodies. Am J Pathol 161:885–894PubMed
23.
Zurück zum Zitat Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Huliman M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller d, Blancato J, Hardy J, Gwinn-Hardy K (2003) α-Synuclein locus triplication causes Parkinson’s disease. Science 302:841. doi:10.1126/science.1090278 PubMedCrossRef Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Huliman M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller d, Blancato J, Hardy J, Gwinn-Hardy K (2003) α-Synuclein locus triplication causes Parkinson’s disease. Science 302:841. doi:10.​1126/​science.​1090278 PubMedCrossRef
27.
Zurück zum Zitat Tabner BJ, Turnbull S, El-Agnaf OMA, Allsop D (2002) Formation of hydrogen peroxide and hydroxyl radicals from Aβ and α-synuclein as a possible mechanism of cell death in Alzheimer’s disease and Parkinson’s disease. Free Radic Biol Med 32:1076–1083. doi:10.1016/S0891-5849(02)00801-8 PubMedCrossRef Tabner BJ, Turnbull S, El-Agnaf OMA, Allsop D (2002) Formation of hydrogen peroxide and hydroxyl radicals from Aβ and α-synuclein as a possible mechanism of cell death in Alzheimer’s disease and Parkinson’s disease. Free Radic Biol Med 32:1076–1083. doi:10.​1016/​S0891-5849(02)00801-8 PubMedCrossRef
28.
30.
Metadaten
Titel
Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson’s disease and dementia with Lewy bodies
verfasst von
John H. T. Power
Peter C. Blumbergs
Publikationsdatum
01.01.2009
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 1/2009
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-008-0438-3

Weitere Artikel der Ausgabe 1/2009

Acta Neuropathologica 1/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.